Scarica l'app Stockscreener
40.73
0.72%
0.29
Dopo l'orario di chiusura:
40.73
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$40.44
Aprire:
$40.32
Volume 24 ore:
2.07M
Relative Volume:
0.98
Capitalizzazione di mercato:
$6.18B
Reddito:
$3.24B
Utile/perdita netta:
$304.90M
Rapporto P/E:
19.58
EPS:
2.08
Flusso di cassa netto:
$156.70M
1 W Prestazione:
+2.70%
1M Prestazione:
+11.71%
6M Prestazione:
-33.60%
1 anno Prestazione:
-41.85%
Intervallo 1D:
$40.28
$41.00
Intervallo di 1 settimana:
$38.60
$41.00
Portata 52W:
$34.10
$79.78
Bruker Corp Stock (BRKR) Company Profile
Nome
Bruker Corp
Settore
Industria
Telefono
978663-3660
Indirizzo
40 MANNING RD, BILLERICA, MA
Confronta BRKR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
40.73 | 6.18B | 3.24B | 304.90M | 156.70M | 2.08 |
|
ABT
Abbott Laboratories
|
132.60 | 224.65B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.24 | 151.13B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
381.36 | 139.34B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.45 | 107.01B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.11 | 44.25B | 5.54B | 4.18B | 259.90M | 7.00 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-19 | Iniziato | Guggenheim | Buy |
| 2024-12-10 | Iniziato | UBS | Neutral |
| 2024-12-05 | Aggiornamento | Goldman | Sell → Neutral |
| 2024-10-15 | Iniziato | Barclays | Overweight |
| 2024-09-30 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-02-14 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-12-19 | Iniziato | Wells Fargo | Equal Weight |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2022-10-21 | Iniziato | UBS | Buy |
| 2022-08-22 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-10-15 | Ripresa | Cowen | Market Perform |
| 2021-06-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2021-02-05 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-12-02 | Iniziato | Goldman | Sell |
| 2020-11-16 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2020-05-01 | Downgrade | Cleveland Research | Buy → Neutral |
| 2020-04-02 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| 2020-04-01 | Downgrade | Needham | Strong Buy → Hold |
| 2020-03-26 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Hold |
| 2019-09-26 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | Aggiornamento | Goldman | Sell → Neutral |
| 2019-06-24 | Reiterato | Needham | Strong Buy |
| 2019-06-21 | Reiterato | BofA/Merrill | Neutral |
| 2019-05-30 | Iniziato | Wolfe Research | Peer Perform |
| 2019-05-06 | Reiterato | Needham | Strong Buy |
| 2019-05-03 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-03 | Aggiornamento | UBS | Sell → Neutral |
| 2019-04-12 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2019-02-12 | Reiterato | BTIG Research | Buy |
| 2019-01-03 | Iniziato | Needham | Strong Buy |
Mostra tutto
Bruker Corp Borsa (BRKR) Ultime notizie
Nanorobots Market Size to Exceed USD 38,660 Million by 2034, Rising Demand for Targeted Drug Delivery is Driving Market Growth. - GlobeNewswire Inc.
Bruker announces majority acquisition of RECIPE, a leading provider of mass spectrometry-based diagnostic assay kits for therapeutic drug monitoring - Select Science
Press Release Distribution & PR Platform - ACCESS Newswire
Bruker to launch Beacon Discovery at AACR 2025, expanding access to live single-cell functional analysis - Select Science
Bruker Spatial Biology Pushes Boundaries in Spatial Biology and Multiomics at AACR 2025 - Stock Titan
Bruker to Launch Beacon Discovery™ at AACR 2025, Expanding Access to Live Single-Cell Functional Analysis - Financial Times
Bruker Corporation (BRKR): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025 - Insider Monkey
A Glimpse Into The Expert Outlook On Bruker Through 6 Analysts - Benzinga
Bruker to invest in German company RECIPE - Yahoo Finance
Bruker Introduces nVista 2P Miniature Microscope - Quantisnow
BRUKER CORP : Results of Operations and Financial Condition, Regulation FD Disclosure (form 8-K) - marketscreener.com
Bruker (BRKR) Acquires Majority Stake in RECIPE Chemicals + Instruments | BRKR Stock News - GuruFocus
Bruker Announces Majority Acquisition of RECIPE, a Leading Provider of Mass Spectrometry-based Diagnostic Assay Kits for Therapeutic Drug Monitoring - Yahoo Finance
Bruker (BRKR) Acquires Majority Stake in RECIPE Chemicals + Inst - GuruFocus
Bruker Stock May Benefit Following Its Investment in Ridom GmbH - Yahoo Finance
Bruker (BRKR) Projects Revenue Growth Amid Mixed Segment Performance | BRKR Stock News - GuruFocus
Form DEF 14A BRUKER CORP For: May 29 - StreetInsider
Why Is Life Science Focused Bruker Stock Trading Higher On Friday?Bruker (NASDAQ:BRKR) - Benzinga
Bruker Debuts Fourier 80 Multinuclear Benchtop FT-NMR: Stock to Gain? - Yahoo Finance
Bruker Crushes Q1 Revenue Estimates: Double-Digit Growth Signals Strong Performance - Stock Titan
Bruker Complements Fast, Cost-effective IR Biotyper® Hospital Hygiene Testing and HAI Tracing with NGS Reflex Testing – Company AnnouncementFT.com - Financial Times
Bruker Launches FoodScreener Module for Comprehensive NMR-based Profiling of Honey - Global Food Industry News
Is Now An Opportune Moment To Examine Bruker Corporation (NASDAQ:BRKR)? - Yahoo Finance
Bruker Announces Groundbreaking 1.3 GHz NMR System, Stock Up - Nasdaq
Bruker unveils world’s first 1.3 GHz NMR spectrometer - Investing.com
Bruker Announces First-of-a-kind 1.3 GHz High-Resolution NMR System - Financial Times
Bruker Introduces Innovative Fourier 80 Multinuclear Benchtop FT-NMR – Company Announcement - Financial Times
Revolutionary Multi-Nuclear NMR Technology Transforms Pharma and Battery Research - Stock Titan
Bruker Introduces Breakthrough d-DNP Polarizer: Stock to Gain? - MSN
Should You Think About Buying Bruker Corporation (NASDAQ:BRKR) Now? - simplywall.st
Bruker installs novel MRI polarizer at UCSF for cancer research - Investing.com
Bruker Announces Introduction of Revolutionary d-DNP Polarizer for MRI Research and for Dynamic Nuclear Polarization Liquids NMR – Company AnnouncementFT.com - Financial Times
Game-Changing MRI Breakthrough: New Technology Delivers 10,000x Better Imaging for Cancer Research - Stock Titan
Bruker stock hits 52-week low at $42.68 amid market challenges By Investing.com - Investing.com South Africa
Bruker stock hits 52-week low at $42.68 amid market challenges - Investing.com
Is Bruker Corporation (BRKR) an Oversold Value Stock to Buy According to Hedge Funds? - Insider Monkey
Bruker : Introduces eWARP, a Pioneering New EBSD Detector for Advanced Materials Characterization in Scanning Electron Microscopes - MarketScreener
Bruker stock hits 52-week low at $44 amid market challenges By Investing.com - Investing.com South Africa
Bruker stock hits 52-week low at $44 amid market challenges - Investing.com
Victory Capital Management Inc. Decreases Stock Holdings in Bruker Co. (NASDAQ:BRKR)Insurance News - InsuranceNewsNet
Bruker Corporation (BRKR): Among Michael Burry’s Top Holdings - Insider Monkey
Based On Its ROE, Is Bruker Corporation (NASDAQ:BRKR) A High Quality Stock? - Yahoo Finance
Michael Burry’s Top Holdings Were Gaining While NVDA Was Crashing - Insider Monkey
Bruker Co. (NASDAQ:BRKR) Shares Sold by Charles Schwab Investment Management Inc. - Defense World
FY2027 Earnings Estimate for Bruker Issued By Zacks Research - Defense World
BioSpin's Innovations to Support Bruker Shares, Macro Issues to Ail - Yahoo Finance
Bruker Co. (NASDAQ:BRKR) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
Bruker at Leerink Conference: Navigating Challenges and Opportunities By Investing.com - Investing.com South Africa
Bruker at Leerink Conference: Navigating Challenges and Opportunities - Investing.com
Research Tools & Consumables Stocks Q4 Recap: Benchmarking Bruker (NASDAQ:BRKR) - Yahoo Finance
Bruker at Barclays Healthcare Conference: Navigating Headwinds and Tailwinds By Investing.com - Investing.com South Africa
Bruker Corp Azioni (BRKR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
11.62%
0.20%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):